Sdc2tm1d(KOMP)Wtsi
Targeted Allele Detail
|
|
| Symbol: |
Sdc2tm1d(KOMP)Wtsi |
| Name: |
syndecan 2; targeted mutation 1d, Wellcome Trust Sanger Institute |
| MGI ID: |
MGI:6364847 |
| Gene: |
Sdc2 Location: Chr15:32920869-33034867 bp, + strand Genetic Position: Chr15, 13.74 cM
|
| Alliance: |
Sdc2tm1d(KOMP)Wtsi page
|
| IMPC: |
Sdc2 gene page |
|
| Mutant Cell Line: |
EPD0107_2_G11 |
| Germline Transmission: |
Earliest citation of germline transmission:
J:276769
|
| Parent Cell Line: |
JM8.F6 (ES Cell)
|
| Strain of Origin: |
C57BL/6N
|
| Project Collection: |
KOMP-CSD
|
|
| Allele Type: |
|
Targeted (Null/knockout) |
| Mutations: |
|
Insertion, Intragenic deletion
Vector: L1L2_Bact_P
|
| |
|
Mutation details: The L1L2_Bact_P cassette was inserted at position 33023250 of Chromosome 15 upstream of the critical exon 3 (Build GRCm39). The cassette is composed of an FRT site followed by lacZ sequence and a loxP site. This first loxP site is followed by a neomycin resistance gene under the control of the human beta-actin promoter, SV40 polyA, a second FRT site and a second loxP site. A third loxP site is inserted downstream of the targeted exon 3 at position 33024207. The critical exon 3 is thus flanked by loxP sites. A "conditional ready" (floxed) allele was be created by flp recombinase expression in mice carrying this allele. Subsequent cre expression resulted in a knockout mouse. Further information on targeting strategies used for this and other IKMC alleles can be found at http://www.informatics.jax.org/mgihome/nomen/IKMC_schematics.shtml
(J:276769)
|
|
|
View phenotypes and curated references for all genotypes (concatenated display).
|
| Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
| Carrying this Mutation: |
Mouse Strains: 0 strains available
Cell Lines: 0 lines available
|
| Carrying any Sdc2 Mutation: |
16 strains or lines available
|
|
| Original: |
J:276769 Corti F, et al., N-terminal syndecan-2 domain selectively enhances 6-O heparan sulfate chains sulfation and promotes VEGFA165-dependent neovascularization. Nat Commun. 2019 Apr 5;10(1):1562 |
| All: |
1 reference(s) |
|